Attendo AB (SE:ATT)
:ATT
Want to see SE:ATT full AI Analyst Report?
Top Page
Attendo AB
(ATT)
Select Model
Select Model
Rating:63Neutral
Price Target:
kr112.00
▲(40.53% Upside)
Action:ReiteratedDate:05/09/26
The score is primarily driven by improving profitability and strong free-cash-flow generation, offset by elevated leverage and a major TTM revenue decline that raises near-term business quality concerns. Technicals are supportive with a clear uptrend and neutral momentum, while valuation is roughly mid-range with a low dividend yield.
Positive Factors
Strong free cash flow
Attendo converts a high share of reported earnings into free cash flow consistently, with FCF roughly 85–94% of net income and positive multi-year FCF growth. Durable cash generation supports reinvestment, working-capital cushions, debt service and strategic optionality over months.
Negative Factors
Elevated leverage
Net leverage near three times equity constrains financial flexibility and raises interest-rate and refinancing sensitivity. Persistent high debt limits capacity for capex, acquisitions or dividend policy adjustments and increases vulnerability to shocks in a 2–6 month planning horizon.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong free cash flow
Attendo converts a high share of reported earnings into free cash flow consistently, with FCF roughly 85–94% of net income and positive multi-year FCF growth. Durable cash generation supports reinvestment, working-capital cushions, debt service and strategic optionality over months.
Read all positive factors
Attendo AB (ATT) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr15.87B
Dividend Yield1.47%
Average Volume (3M)307.31K
Price to Earnings (P/E)18.8
Beta (1Y)0.56
Revenue Growth-2.19%
EPS Growth76.78%
CountrySE
Employees33,000
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)5.93
Shares Outstanding151,196,120
10 Day Avg. Volume430,436
30 Day Avg. Volume307,315
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)2.24
Price to Sales (P/S)0.64
P/FCF Ratio4.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.64
Revenue Forecast (FY)kr19.10B
Attendo AB Business Overview & Revenue Model
Company Description
Attendo AB (publ) provides financed care services in Sweden, Finland, Norway, and Denmark. The company offers care services for older people in nursing homes and home care. It also provides disabilities care services for people with disabilities, ...
How the Company Makes Money
Attendo makes money mainly by providing care services that are financed by the public sector and paid for under contracts or placement decisions from local authorities. Its core revenue stream comes from operating residential care facilities (e.g....
Attendo AB Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
48
Neutral
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.91B | 18.99B | 18.98B | 17.29B | 14.50B | 12.87B |
| Gross Profit | 526.00M | 3.20B | 8.20B | 5.92B | 1.52B | 1.42B |
| EBITDA | 3.95B | 3.87B | 3.44B | 3.05B | 2.18B | 1.99B |
| Net Income | 875.00M | 813.00M | 450.00M | 376.00M | -45.00M | 56.00M |
Balance Sheet | ||||||
| Total Assets | 24.39B | 25.05B | 25.24B | 22.89B | 22.32B | 21.08B |
| Cash, Cash Equivalents and Short-Term Investments | 733.00M | 1.27B | 821.00M | 922.00M | 507.00M | 513.00M |
| Total Debt | 15.83B | 16.44B | 16.74B | 14.75B | 14.80B | 13.88B |
| Total Liabilities | 18.93B | 19.60B | 19.91B | 17.53B | 17.32B | 16.12B |
| Stockholders Equity | 5.45B | 5.45B | 5.33B | 5.36B | 5.00B | 4.93B |
Cash Flow | ||||||
| Free Cash Flow | 2.80B | 2.65B | 2.26B | 2.08B | 1.13B | 1.21B |
| Operating Cash Flow | 2.99B | 2.85B | 2.46B | 2.23B | 1.33B | 1.38B |
| Investing Cash Flow | -196.00M | -330.00M | -1.24B | -185.00M | -390.00M | -413.00M |
| Financing Cash Flow | -2.53B | -2.04B | -1.33B | -1.63B | -970.00M | -1.18B |
Attendo AB Technical Analysis
Positive
79.70
Price Trends
102.27
Positive
92.88
Positive
81.39
Positive
Market Momentum
1.96
Negative
58.23
Neutral
60.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ATT, the sentiment is Positive. The current price of 79.7 is below the 20-day moving average (MA) of 103.48, below the 50-day MA of 102.27, and below the 200-day MA of 81.39, indicating a bullish trend. The MACD of 1.96 indicates Negative momentum. The RSI at 58.23 is Neutral, neither overbought nor oversold. The STOCH value of 60.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:ATT.
Attendo AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | kr7.67B | 31.40 | 15.16% | ― | 18.06% | 10.57% | |
68 Neutral | kr11.63B | 16.37 | 12.96% | 1.56% | 15.74% | 15.67% | |
67 Neutral | kr1.69B | 12.47 | ― | ― | 12.25% | -49.24% | |
63 Neutral | kr15.87B | 18.84 | ― | 1.47% | -2.19% | 76.78% | |
61 Neutral | kr1.68B | 143.44 | ― | ― | ― | ― | |
58 Neutral | kr2.53B | 15.17 | 7.53% | 2.01% | -4.47% | 6.10% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
SE:ATT
Attendo AB
104.50
43.24
70.57%
SE:HUM
Humana AB
48.15
11.30
30.66%
SE:AMBEA
Ambea AB
148.00
42.49
40.27%
SE:MCAP
MedCap AB
529.00
72.00
15.75%
SE:SUS
Surgical Science Sweden AB
33.14
-117.36
-77.98%
SE:CARA
Carasent AB
24.30
0.20
0.83%
Attendo AB Corporate Events
Attendo AGM Backs Dividend, New Incentive Plans and Capital Changes
May 6, 2026
Attendo AB’s Annual General Meeting re-elected Ulf Mattsson as chair of a six-member board and appointed PwC as auditor until 2027, while approving the 2025 financial statements, remuneration report and releasing the board and CEO from liabi...
Attendo Launches SEK 275 Million Share Buyback to Optimize Capital Structure
May 6, 2026
Attendo’s board has approved a share buyback program of up to SEK 275 million, aiming to optimize the company’s capital structure and provide shares for existing incentive programs for employees and management. The repurchases, which w...
Attendo’s Unika expands specialised Prader–Willi care with new Mölndal unit
May 6, 2026
Attendo’s Unika brand, which consolidates its Swedish LSS disability services, has opened a new specialised unit in Mölndal for people with Prader–Willi syndrome, a rare condition requiring highly adapted support. The residence is...
Attendo Boosts Profitability on Higher Occupancy Despite Sales Dip
May 6, 2026
Attendo reported continued positive development across its business areas in the first quarter of 2026, driven by higher occupancy and improved operational efficiency, which helped lift adjusted earnings per share to 6.47 SEK on a rolling 12‑...
Attendo crosses 5% threshold in ongoing share buyback programme
Apr 29, 2026
Attendo AB has disclosed that it repurchased 25,000 of its own shares on 28 April 2026, bringing its total holding of treasury shares to 7,569,713, or 5.01 percent of the company’s outstanding shares. Crossing the five percent threshold trig...
Attendo strengthens Finnish addiction care footprint with A-klinikka acquisition
Apr 28, 2026
Attendo Finland has agreed to acquire A-klinikka Oy, a Finnish provider of substance abuse and addiction treatment services with about 300 employees and contracts across multiple welfare regions and the City of Helsinki. The deal strengthens Atten...
Attendo to Webcast First-Quarter 2026 Results for Investors
Apr 22, 2026
Attendo AB, the leading Nordic provider of social and healthcare services with around 770 units and 33,000 employees in Finland, Sweden and Denmark, continues to position itself as a key private player in addressing regional care challenges. The N...
Attendo Advances SEK 200m Share Buyback, Lifts Treasury Share Holding
Apr 21, 2026
Attendo AB has continued its ongoing share buyback programme, repurchasing 225,000 shares on Nasdaq Stockholm during the week of 13–17 April 2026 for a total of about SEK 24.2 million. The transactions, executed by DNB Carnegie Investment Ba...
Attendo Corrects Notice on Share Buybacks and Confirms Scope of Treasury Purchases
Apr 8, 2026
Attendo AB corrected an earlier disclosure and confirmed that it repurchased 175,000 of its own shares between 30 March and 3 April 2026 under a share buyback programme of up to SEK 200 million. The purchases, executed on Nasdaq Stockholm by DNB C...
Attendo Boosts Share Buyback as Nordic Care Operations Expand
Mar 31, 2026
Attendo AB, the Nordic care provider specialising in elderly care, disability services and social care, continues to expand its footprint across Finland, Sweden and Denmark with a workforce of about 33,000 employees. The group runs some 800 local ...
Attendo Releases 2025 Annual and Sustainability Report in Line with New EU Standards
Mar 31, 2026
Attendo AB has published its Annual and Sustainability Report for 2025, presenting audited annual and consolidated accounts alongside a comprehensive directors’ report. The report is officially prepared in Swedish in the single electronic re...
Attendo Corrects AGM Notice and Confirms Meeting Details in Danderyd
Mar 26, 2026
Attendo AB has corrected the address information for its upcoming Annual General Meeting, confirming it will take place at the company’s head office on Vendevägen 85B in Danderyd, Sweden, on 6 May 2026. The meeting will be held in a sma...
Attendo Nomination Committee Proposes Streamlined, Diversity-Focused Board Ahead of 2026 AGM
Mar 25, 2026
Attendo’s Nomination Committee has outlined its work ahead of the 2026 Annual General Meeting, detailing its composition changes after Nordstjernan’s divestment and confirming that it has followed the Swedish Corporate Governance Code ...
Attendo Sets Smaller-Format AGM for May With Expanded Advance Voting Options
Mar 25, 2026
Attendo AB has called its Annual General Meeting for 6 May 2026 in Danderyd, Sweden, and will conduct the event in a smaller physical format with limited refreshments while also allowing shareholders to exercise their voting rights in advance. The...
Attendo Steps Up Share Buybacks Under SEK 200m Programme
Mar 24, 2026
Attendo AB has continued its share buyback programme, repurchasing 145,000 shares on Nasdaq Stockholm during the week of 16–20 March 2026 at a weighted average price of SEK 101.31, for a total of about SEK 14.7 million. The purchases form pa...
Attendo steps up SEK 200m share buyback with new repurchases
Mar 17, 2026
Attendo AB has continued to execute its previously announced share buyback programme, repurchasing 150,000 of its own shares on Nasdaq Stockholm between 9 and 13 March 2026. The purchases, carried out by DNB Carnegie Investment Bank on AttendoR...
Attendo Sets Out Updated Financial Targets and Strategy at Capital Markets Day
Mar 17, 2026
Attendo AB is the leading Nordic care provider, offering elderly care, disability services and social care through about 800 units in Finland, Sweden and Denmark. With a workforce of around 33,000 employees, the company is positioned as a key play...
Attendo steps up Nordic care group buyback with 100,000-share repurchase
Mar 10, 2026
Attendo AB continued its share buyback programme in week 10 of 2026, repurchasing 100,000 shares on Nasdaq Stockholm between 2 and 5 March at a weighted average price of SEK 101.53, for a total of about SEK 10.2 million. These transactions, execut...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.